latest news:

04.04.2013:

ChromoTek’s fluorescent two hybrid (F2H®) technology enables screening and validation of compounds in living cells

04.04.2013:

Push For Smart Industry: ChromoTek wins category "Biotechnology" and the overall first prize from 1200 participating companies.

28.03.2013:

Visit us at the annual meeting of the American Association for Cancer Research, booth 1038!

18.03.2013:

ChromoTek's Chromobody® Technology for High Content drug profiling licensed to Bayer

Displaying results 1 to 4 out of 31

ChromoTek order line
Fax: +49. 89. 78 79 73 11
order(at)chromotek.com

Imprint